This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 97/7/725    most recent 01.RES.0000183730.52908.C6v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jonas, M. Articles by Rogers, C. Search for Related Content PubMed PubMed Citation Articles by Jonas, M. Articles by Rogers, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Obesity Hazardous Substances DB STREPTOZOTOCIN

(Circulation Research. 2005;97:725.)
© 2005 American Heart Association, Inc.

Integrative Physiology

Vascular Neointimal Formation and Signaling Pathway Activation in Response to Stent Injury in Insulin-Resistant and Diabetic Animals

Michael Jonas, Elazer R. Edelman, Adam Groothuis, Aaron B. Baker, Philip Seifert, Campbell Rogers

From the Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston (M.J., E.R.E., C.R.), and the Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge (M.J., E.R.E., A.G., A.B.B., P.S., C.R.), Mass.

Correspondence to Campbell Rogers, MD, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail crogers{at}mit.edu

Diabetes and insulin resistance are associated with increased disease risk and poor outcomes from cardiovascular interventions. Even drug-eluting stents exhibit reduced efficacy in patients with diabetes. We now report the first study of vascular response to stent injury in insulin-resistant and diabetic animal models. Endovascular stents were expanded in the aortae of obese insulin-resistant and type 2 diabetic Zucker rats, in streptozotocin-induced type 1 diabetic Sprague-Dawley rats, and in matched controls. Insulin-resistant rats developed thicker neointima (0.46±0.08 versus 0.37±0.06 mm², P=0.05), with decreased lumen area (2.95±0.26 versus 3.29±0.15 mm², P=0.03) 14 days after stenting compared with controls, but without increased vascular inflammation (ED1+ tissue macrophages). Insulin-resistant and diabetic rat vessels did exhibit markedly altered signaling pathway activation 1 and 2 weeks after stenting, with up to a 98% increase in p-ERK (anti-phospho ERK) and a 54% reduction in p-Akt (anti-phospho Akt) stained cells. Western blotting confirmed a profound effect of insulin resistance and diabetes on Akt and ERK signaling in stented segments. p-ERK/p-Akt ratio in stented segments uniquely correlated with neointimal response (R²=0.888, P=0.04) in insulin-resistant and type 1 and 2 diabetic rats, but not in lean controls. Transfemoral aortic stenting in rats provides insight into vascular responses in insulin resistance and diabetes. Shifts in ERK and Akt signaling related to insulin resistance may reflect altered tissue repair in diabetes accompanied by a shift in metabolic:proliferative balance. These findings may help explain the increased vascular morbidity in diabetes and suggest specific therapies for patients with insulin resistance and diabetes.

Key Words: diabetes mellitus • insulin resistance • Akt ERK signaling • stent • restenosis

This article has been cited by other articles:

				J. Chamberlain, M. Wheatcroft, N. Arnold, H. Lupton, D. C. Crossman, J. Gunn, and S. Francis A novel mouse model of in situ stenting Cardiovasc Res, August 12, 2009; (2009) cvp262v2. [Abstract] [Full Text] [PDF]

				C.-S. Lee, Y.-W. Kwon, H.-M. Yang, S.-H. Kim, T.-Y. Kim, J. Hur, K.-W. Park, H.-J. Cho, H.-J. Kang, Y.-B. Park, et al. New Mechanism of Rosiglitazone to Reduce Neointimal Hyperplasia: Activation of Glycogen Synthase Kinase-3{beta} Followed by Inhibition of MMP-9 Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 472 - 479. [Abstract] [Full Text] [PDF]

				A. B. Baker, A. Groothuis, M. Jonas, D. S. Ettenson, T. Shazly, E. Zcharia, I. Vlodavsky, P. Seifert, and E. R. Edelman Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice Circ. Res., February 13, 2009; 104(3): 380 - 387. [Abstract] [Full Text] [PDF]

				A. C Mcmahon, H. Zreiqat, and H. C Lowe Carotid artery stenting in the Zucker rat: a novel, potentially 'diabetes-specific' model of in-stent restenosis Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 145 - 146. [PDF]

				A. Fischoeder, H. Meyborg, D. Stibenz, E. Fleck, K. Graf, and P. Stawowy Insulin augments matrix metalloproteinase-9 expression in monocytes Cardiovasc Res, March 1, 2007; 73(4): 841 - 848. [Abstract] [Full Text] [PDF]

				D. Bruemmer C-Peptide in Insulin Resistance and Vascular Complications: Teaching an Old Dog New Tricks Circ. Res., November 24, 2006; 99(11): 1149 - 1151. [Full Text] [PDF]

				S. P. Salzberg, F. Filsoufi, A. Anyanwu, K. von Harbou, E. Karlof, A. Carpentier, H. M. Dansky, and D. H. Adams Increased Neointimal Formation After Surgical Vein Grafting in a Murine Model of Type 2 Diabetes Circulation, July 4, 2006; 114(1_suppl): I-302 - I-307. [Abstract] [Full Text] [PDF]

				C. Rogers and E. R. Edelman Pushing Drug-Eluting Stents Into Uncharted Territory: Simpler Than You Think--More Complex Than You Imagine Circulation, May 16, 2006; 113(19): 2262 - 2265. [Full Text] [PDF]